Cargando…
The predictive and prognostic value of low skeletal muscle mass for dose-limiting toxicity and survival in head and neck cancer patients receiving concomitant cetuximab and radiotherapy
PURPOSE: This study aims to investigate the predictive value of low skeletal muscle mass (SMM) for cetuximab dose-limiting toxicity (DLT) and its prognostic value in head and neck squamous cell carcinoma (HNSCC) patients treated with concomitant cetuximab and radiotherapy. METHODS: Patients diagnose...
Autores principales: | Huiskamp, L. F. J., Chargi, N., Devriese, L. A., de Jong, P. A., de Bree, R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7496017/ https://www.ncbi.nlm.nih.gov/pubmed/32335709 http://dx.doi.org/10.1007/s00405-020-05972-2 |
Ejemplares similares
-
Low skeletal muscle mass predicts frailty in elderly head and neck cancer patients
por: Meerkerk, C. D. A., et al.
Publicado: (2021) -
Sarcopenia is a prognostic factor for overall survival in elderly patients with head-and-neck cancer
por: Chargi, N., et al.
Publicado: (2019) -
Interobserver agreement of skeletal muscle mass measurement on head and neck CT imaging at the level of the third cervical vertebra
por: Bril, S. I., et al.
Publicado: (2019) -
Obstructive sleep apnoea after radiotherapy for head and neck cancer
por: Leone, Federico, et al.
Publicado: (2020) -
Pretreatment screening for distant metastases in the Dutch head and neck centers: 10 years later
por: Senft, Asaf, et al.
Publicado: (2016)